nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study
|
Osowicki, Joshua |
|
|
|
7 |
p. e291-e299 |
artikel |
2 |
Antibiotic-resistant Acinetobacter baumannii is a One Health problem
|
Hernández-González, Ismael L |
|
|
|
7 |
p. e279 |
artikel |
3 |
Antimalarial drug resistance—is it time to re-evaluate Plasmodium falciparum orthologous genes?
|
Khattak, Aamer Ali |
|
|
|
7 |
p. e472-e473 |
artikel |
4 |
Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis
|
Bell, Sara F E |
|
|
|
7 |
p. e544-e551 |
artikel |
5 |
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study
|
Gibani, Malick M |
|
|
|
7 |
p. e300-e307 |
artikel |
6 |
Association between domesticated animal ownership and Plasmodium falciparum parasite prevalence in the Democratic Republic of the Congo: a national cross-sectional study
|
Morgan, Camille E |
|
|
|
7 |
p. e516-e523 |
artikel |
7 |
Association of IFNAR1 and IFNAR2 with COVID-19 severity
|
Yaugel-Novoa, Melyssa |
|
|
|
7 |
p. e487 |
artikel |
8 |
Avian influenza spillover into mammals
|
Venkatesan, Priya |
|
|
|
7 |
p. e492 |
artikel |
9 |
Biofilm formation and virulence potential of carbapenem-resistant Pseudomonas aeruginosa
|
Ma, Yeping |
|
|
|
7 |
p. e489 |
artikel |
10 |
Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern
|
Mishra, Shyam Kumar |
|
|
|
7 |
p. e482-e483 |
artikel |
11 |
Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic
|
Choy, Kay Weng |
|
|
|
7 |
p. e273-e274 |
artikel |
12 |
Co-infection with SARS-CoV-2 omicron BA.1 and BA.2 subvariants in a non-vaccinated woman
|
Vatteroni, Maria Linda |
|
|
|
7 |
p. e478 |
artikel |
13 |
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
|
Corman, Victor M |
|
|
|
7 |
p. e311-e319 |
artikel |
14 |
Correction to Lancet Microbe 2022; 3: e435–42
|
|
|
|
|
7 |
p. e479 |
artikel |
15 |
Correction to Lancet Microbe 2020; 1: e300–07
|
|
|
|
|
7 |
p. e280 |
artikel |
16 |
Correction to Lancet Microbe 2020; 1: e233–34
|
|
|
|
|
7 |
p. e280 |
artikel |
17 |
Correction to Lancet Microbe 2021; 2: e331–41
|
|
|
|
|
7 |
p. e288 |
artikel |
18 |
Correction to Lancet Microbe 2021; published online April 13. https://doi.org/10.1016/S2666-5247(21)00082-3
|
|
|
|
|
7 |
p. e288 |
artikel |
19 |
Correction to Lancet Microbe 2021; published online April 20. https://doi.org/10.1016/S2666-5247(21)00069-0
|
|
|
|
|
7 |
p. e288 |
artikel |
20 |
COVID-19 response in central Asia
|
Balakrishnan, Vijay Shankar |
|
|
|
7 |
p. e281 |
artikel |
21 |
COVID-19 vaccination among Roma populations in Europe
|
Holt, Ed |
|
|
|
7 |
p. e289 |
artikel |
22 |
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
|
Olliaro, Piero |
|
|
|
7 |
p. e279-e280 |
artikel |
23 |
COVID-19 vaccines: effectiveness and number needed to treat
|
Correia, Luis C L |
|
|
|
7 |
p. e281 |
artikel |
24 |
COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
|
Olliaro, Piero |
|
|
|
7 |
p. e282 |
artikel |
25 |
CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study
|
Huang, Zhen |
|
|
|
7 |
p. e482-e492 |
artikel |
26 |
Cultures matter in microbiology
|
The Lancet Microbe, |
|
|
|
7 |
p. e481 |
artikel |
27 |
Delays in the arrival of the waves of COVID-19: a comparison between Gabon and the African continent
|
Abe, Haruka |
|
|
|
7 |
p. e476 |
artikel |
28 |
Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
|
Buchta, Christoph |
|
|
|
7 |
p. e552-e562 |
artikel |
29 |
Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study
|
Kandasamy, Rama |
|
|
|
7 |
p. e503-e511 |
artikel |
30 |
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
|
Goig, Galo A |
|
|
|
7 |
p. e506-e515 |
artikel |
31 |
Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002–17: a nationwide, longitudinal, microbial population genomic study
|
Gladstone, Rebecca A |
|
|
|
7 |
p. e331-e341 |
artikel |
32 |
Emergence of an epidemic hypervirulent clone of Enterobacter hormaechei coproducing mcr-9 and carbapenemases
|
Xu, Tingting |
|
|
|
7 |
p. e474-e475 |
artikel |
33 |
Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysis
|
Lacey, Jake A |
|
|
|
7 |
p. e524-e533 |
artikel |
34 |
Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study
|
Jeremiah Matson, M |
|
|
|
7 |
p. e533-e542 |
artikel |
35 |
G7 leaders commit to greater pandemic preparedness (again)
|
The Lancet Microbe, |
|
|
|
7 |
p. e276 |
artikel |
36 |
Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation
|
Zhang, Zhenjie |
|
|
|
7 |
p. e512-e520 |
artikel |
37 |
Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study
|
Wajnberg, Ania |
|
|
|
7 |
p. e283-e289 |
artikel |
38 |
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
|
Gazit, Sivan |
|
|
|
7 |
p. e495-e505 |
artikel |
39 |
Immunogenomic phases of COVID-19 and appropriate clinical management
|
Haznedaroglu, Ibrahim C |
|
|
|
7 |
p. e278 |
artikel |
40 |
Increase in extensively drug resistant Shigella sonnei in Europe
|
Trivett, Hannah |
|
|
|
7 |
p. e481 |
artikel |
41 |
Innovative point-of-care molecular diagnostic test for COVID-19 in India
|
Gupta, Nivedita |
|
|
|
7 |
p. e277 |
artikel |
42 |
Investigating One Health risks for human colonisation with extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Malawian households: a longitudinal cohort study
|
Cocker, Derek |
|
|
|
7 |
p. e534-e543 |
artikel |
43 |
Is low-dose tafenoquine combined with dihydroartemisinin-piperaquine a potential risk factor for Plasmodium vivax resistance to 8-aminoquinolines?
|
Lampejo, Temi |
|
|
|
7 |
p. e477 |
artikel |
44 |
Launch of global summit to preserve antimicrobials
|
Barksby, Rebecca |
|
|
|
7 |
p. e493-e494 |
artikel |
45 |
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis
|
Muecksch, Frauke |
|
|
|
7 |
p. e493-e502 |
artikel |
46 |
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis
|
Ramsheh, Mohammadali Yavari |
|
|
|
7 |
p. e300-e310 |
artikel |
47 |
Malawi takes on cholera outbreak amid cyclone devastation
|
Bagcchi, Sanjeet |
|
|
|
7 |
p. e480 |
artikel |
48 |
Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study
|
Zürcher, Kathrin |
|
|
|
7 |
p. e320-e330 |
artikel |
49 |
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
|
Bladh, Oscar |
|
|
|
7 |
p. e488 |
artikel |
50 |
Of CRISPRs, chemistry, and women
|
The Lancet Microbe, |
|
|
|
7 |
p. e272 |
artikel |
51 |
Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19
|
Pan, Daniel |
|
|
|
7 |
p. e286-e287 |
artikel |
52 |
Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer
|
Shamim, Muhammad Aaqib |
|
|
|
7 |
p. e490 |
artikel |
53 |
Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer – Authors' reply
|
Soucy, Jean-Paul R |
|
|
|
7 |
p. e491 |
artikel |
54 |
Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
|
Muramoto, Yukiko |
|
|
|
7 |
p. e486 |
artikel |
55 |
Respiratory viruses in pregnancy—a timely warning
|
Venkatesan, Priya |
|
|
|
7 |
p. e282 |
artikel |
56 |
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
|
Jangra, Sonia |
|
|
|
7 |
p. e283-e284 |
artikel |
57 |
Searching for SARS-CoV-2 origins: the saga continues
|
The Lancet Microbe, |
|
|
|
7 |
p. e471 |
artikel |
58 |
Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2
|
Huang, Baoying |
|
|
|
7 |
p. e285 |
artikel |
59 |
Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
|
McBride, Angela |
|
|
|
7 |
p. e277-e278 |
artikel |
60 |
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
|
Hoenigl, Martin |
|
|
|
7 |
p. e543-e552 |
artikel |
61 |
Thoughts on group A streptococci
|
Yu, Dingle |
|
|
|
7 |
p. e484-e485 |
artikel |
62 |
Using genomics to improve preparedness and response of future epidemics or pandemics in Africa
|
Chaguza, Chrispin |
|
|
|
7 |
p. e275-e276 |
artikel |
63 |
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
|
Schurink, Bernadette |
|
|
|
7 |
p. e290-e299 |
artikel |
64 |
WHO–Germany collaboration for pandemic intelligence research
|
Balakrishnan, Vijay Shankar |
|
|
|
7 |
p. e290 |
artikel |
65 |
Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study
|
Boloko, Linda |
|
|
|
7 |
p. e521-e532 |
artikel |